Spatial contribution of hippocampal BOLD activation in high-resolution fMRI.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 02 2019
Historique:
received: 28 09 2018
accepted: 29 01 2019
entrez: 1 3 2019
pubmed: 1 3 2019
medline: 17 9 2020
Statut: epublish

Résumé

While the vascular origin of the BOLD-fMRI signal is established, the exact neurovascular coupling events contributing to this signal are still incompletely understood. Furthermore, the hippocampal spatial properties of the BOLD activation are not elucidated, although electrophysiology approaches have already revealed the precise spatial patterns of neural activity. High magnetic field fMRI offers improved contrast and allows for a better correlation with the underlying neuronal activity because of the increased contribution to the BOLD signal of small blood vessels. Here, we take advantage of these two benefits to investigate the spatial characteristics of the hippocampal activation in a rat model before and after changing the hippocampal plasticity by long-term potentiation (LTP). We found that the hippocampal BOLD signals evoked by electrical stimulation at the perforant pathway increased more at the radiatum layer of the hippocampal CA1 region than at the pyramidal cell layer. The return to the baseline of the hippocampal BOLD activation was prolonged after LTP induction compared with that before most likely due vascular or neurovascular coupling changes. Based on these results, we conclude that high resolution BOLD-fMRI allows the segregation of hippocampal subfields probably based on their underlying vascular or neurovascular coupling features.

Identifiants

pubmed: 30816226
doi: 10.1038/s41598-019-39614-3
pii: 10.1038/s41598-019-39614-3
pmc: PMC6395694
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3152

Références

J Physiol. 2006 Oct 15;576(Pt 2):427-43
pubmed: 16873414
Dev Cogn Neurosci. 2011 Jul;1(3):199-216
pubmed: 22436508
J Cereb Blood Flow Metab. 2017 Feb;37(2):590-604
pubmed: 26911895
J Neurophysiol. 2003 Aug;90(2):1314-23
pubmed: 12904510
Front Neuroanat. 2010 Jan 11;3:31
pubmed: 20161698
Nature. 2010 Nov 11;468(7321):232-43
pubmed: 21068832
Biochem Biophys Res Commun. 2009 Jun 5;383(3):326-30
pubmed: 19358832
J Neurophysiol. 2008 Mar;99(3):1235-42
pubmed: 18199817
Neuroimage. 2007 Oct 15;38(1):150-63
pubmed: 17728153
Neuroimage. 2013 Jul 15;75:213-227
pubmed: 23507376
Front Pharmacol. 2015 Oct 21;6:231
pubmed: 26539115
Brain Res. 2001 Aug 10;910(1-2):81-93
pubmed: 11489257
Front Neural Circuits. 2016 Feb 10;10:2
pubmed: 26903815
Nat Methods. 2012 Jun;9(6):597-602
pubmed: 22561989
Nature. 2009 Jan 22;457(7228):475-9
pubmed: 19158795
Neuron. 2018 Feb 21;97(4):925-939.e5
pubmed: 29398359
Front Neural Circuits. 2012 Sep 12;6:64
pubmed: 22988432
Neuron. 1998 Aug;21(2):425-33
pubmed: 9728923
J Neurosci. 2009 Feb 25;29(8):2428-39
pubmed: 19244518
J Neurophysiol. 2007 Sep;98(3):1309-22
pubmed: 17615129
Nat Methods. 2016 Apr;13(4):337-40
pubmed: 26855362
PLoS One. 2010 Sep 23;5(9):e12966
pubmed: 20886034
Neuroscience. 2011 Mar 31;178:21-32
pubmed: 21256195
Proc Natl Acad Sci U S A. 1990 Dec;87(24):9868-72
pubmed: 2124706
Dialogues Clin Neurosci. 2009;11(3):281-95
pubmed: 19877496
Front Neuroanat. 2017 Dec 19;11:128
pubmed: 29311856
Nature. 2001 Jul 12;412(6843):150-7
pubmed: 11449264
Neuron. 2015 Jul 1;87(1):95-110
pubmed: 26119027
PLoS Biol. 2012 Feb;10(2):e1001259
pubmed: 22347811
Nature. 2016 May 25;534(7607):378-82
pubmed: 27281215
Curr Biol. 2009 Mar 10;19(5):398-403
pubmed: 19230667
J Cogn Neurosci. 2008 Jul;20(7):1300-14
pubmed: 18284348
Neuroimage. 2010 May 1;50(4):1364-75
pubmed: 20114080
PLoS One. 2013;8(3):e57694
pubmed: 23469218
J Neurosci. 1995 Jan;15(1 Pt 1):30-46
pubmed: 7823136
Neuroimage. 2015 Jun;113:37-43
pubmed: 25795340
Philos Trans R Soc Lond B Biol Sci. 2013 Dec 02;369(1633):20130152
pubmed: 24298154

Auteurs

Yoshifumi Abe (Y)

Commissariat à l'énergie atomique et aux energies alternatives, DRF, Joliot, NeuroSpin, Paris-Saclay University, Gif-sur-Yvette, France.

Tomokazu Tsurugizawa (T)

Commissariat à l'énergie atomique et aux energies alternatives, DRF, Joliot, NeuroSpin, Paris-Saclay University, Gif-sur-Yvette, France.

Denis Le Bihan (D)

Commissariat à l'énergie atomique et aux energies alternatives, DRF, Joliot, NeuroSpin, Paris-Saclay University, Gif-sur-Yvette, France.

Luisa Ciobanu (L)

Commissariat à l'énergie atomique et aux energies alternatives, DRF, Joliot, NeuroSpin, Paris-Saclay University, Gif-sur-Yvette, France. luisa.ciobanu@cea.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH